{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:11:23Z","timestamp":1791357083651,"version":"4.3.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["T32 MH14654"],"award-info":[{"award-number":["T32 MH14654"]}]},{"name":"NIH","award":["U01 MH72832"],"award-info":[{"award-number":["U01 MH72832"]}]},{"name":"NIH","award":["R01 MH86599"],"award-info":[{"award-number":["R01 MH86599"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.neuropharm.2012.11.027","type":"journal-article","created":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T10:47:22Z","timestamp":1354790842000},"page":"503-510","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Brain monoamines and antidepressant-like responses in MRL\/MpJ versus C57BL\/6J mice"],"prefix":"10.1016","volume":"67","author":[{"given":"Darrick T.","family":"Balu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill R.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany R.","family":"Brookshire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany E.","family":"Hill-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Blendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irwin","family":"Lucki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.11.027_bib1","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1038\/npp.2008.234","article-title":"Enhanced sensitivity of the MRL\/MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatments","volume":"34","author":"Balu","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.027_bib2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.neubiorev.2008.08.007","article-title":"Adult hippocampal neurogenesis: regulation, functional implications, and contribution to disease pathology","volume":"33","author":"Balu","year":"2009","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0014-2999(92)90292-C","article-title":"Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in\u00a0vivo microdialysis study","volume":"229","author":"Bel","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0091-3057(01)00701-8","article-title":"Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents","volume":"71","author":"Brocco","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib5","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.pharmthera.2011.01.014","article-title":"Immune system to brain signaling: neuropsychopharmacological implications","volume":"130","author":"Capuron","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1006\/clin.1998.4519","article-title":"A\u00a0new murine model for mammalian wound repair and regeneration","volume":"88","author":"Clark","year":"1998","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib7","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/sj.npp.1301287","article-title":"Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies","volume":"32","author":"Cremers","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.11.027_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00213-005-0166-5","article-title":"Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test","volume":"183","author":"Crowley","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.11.027_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2174\/1381612053382278","article-title":"Opportunities to discover genes regulating depression and antidepressant response from rodent behavioral genetics","volume":"11","author":"Crowley","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib10","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.neubiorev.2005.03.009","article-title":"The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib11","doi-asserted-by":"crossref","first-page":"8186","DOI":"10.1073\/pnas.0401080101","article-title":"Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors","volume":"101","author":"Cryan","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/syn.890090104","article-title":"[3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region","volume":"9","author":"Dewar","year":"1991","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2012.11.027_bib13","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A\u00a0neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.027_bib14","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Franklin","year":"1997"},{"issue":"Suppl. 6","key":"10.1016\/j.neuropharm.2012.11.027_bib15","first-page":"9","article-title":"Antidepressants","volume":"58","author":"Frazer","year":"1997","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.027_bib16","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00210-004-0939-0","article-title":"Antidepressant-like effects of the nociceptin\/orphanin FQ receptor antagonist UFP-101: new evidence from rats and mice","volume":"369","author":"Gavioli","year":"2004","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib17","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1046\/j.1471-4159.1997.69062616.x","article-title":"Alpha2-adrenergic receptor blockade markedly potentiates duloxetine- and fluoxetine-induced increases in noradrenaline, dopamine, and serotonin levels in the frontal cortex of freely moving rats","volume":"69","author":"Gobert","year":"1997","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.ta.0000196802.91829.cc","article-title":"Norepinephrine modulates the inflammatory and proliferative phases of wound healing","volume":"60","author":"Gosain","year":"2006","journal-title":"J.\u00a0Trauma"},{"key":"10.1016\/j.neuropharm.2012.11.027_bib19","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1098\/rstb.2004.1468","article-title":"The scarless heart and the MRL mouse","volume":"359","author":"Heber-Katz","year":"2004","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/026988110001400208","article-title":"Serotonin autoreceptor function and antidepressant drug action","volume":"14","author":"Hjorth","year":"2000","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib21","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1124\/jpet.109.158717","article-title":"Sex-specific effects of chronic fluoxetine treatment on neuroplasticity and pharmacokinetics in mice","volume":"332","author":"Hodes","year":"2010","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib22","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.pbb.2006.05.021","article-title":"Effects of the mGluR2\/3 agonist LY379268 on ketamine-evoked behaviours and neurochemical changes in the dentate gyrus of the rat","volume":"84","author":"Imre","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib23","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/S0022-3565(24)29478-7","article-title":"Regional patterns of compensation following genetic deletion of either 5-hydroxytryptamine(1A) or 5-hydroxytryptamine(1B) receptor in the mouse","volume":"298","author":"Knobelman","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib24","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0022-3565(24)29477-5","article-title":"Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse","volume":"298","author":"Knobelman","year":"2001","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib25","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S0022-3565(24)35396-0","article-title":"Regulation of extracellular concentrations of 5-hydroxytryptamine (5-HT) in mouse striatum by 5-HT(1A) and 5-HT(1B) receptors","volume":"292","author":"Knobelman","year":"2000","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib26","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0022-3565(25)38872-5","article-title":"Differential regulation of serotonin (5-HT) release in the striatum and hippocampus by 5-HT1A autoreceptors of the dorsal and median raphe nuclei","volume":"269","author":"Kreiss","year":"1994","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib27","doi-asserted-by":"crossref","first-page":"9830","DOI":"10.1073\/pnas.181329398","article-title":"Heart regeneration in adult MRL mice","volume":"98","author":"Leferovich","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130100694","article-title":"Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice","volume":"155","author":"Lucki","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.11.027_bib29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/mp.2010.80","article-title":"The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?","volume":"16","author":"MacQueen","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.11.027_bib30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1046\/j.1471-4159.2001.00083.x","article-title":"5-HT1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex","volume":"76","author":"Malagie","year":"2001","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.mehy.2003.10.021","article-title":"Treatment with selective serotonin reuptake inhibitors for enhancing wound healing","volume":"63","author":"Malinin","year":"2004","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neuropharm.2012.11.027_bib32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s002130100687","article-title":"Limitations on the use of the C57BL\/6 mouse in the tail suspension test","volume":"155","author":"Mayorga","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.11.027_bib33","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00213-007-0728-9","article-title":"Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test","volume":"192","author":"O'Leary","year":"2007","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.11.027_bib34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1023\/A:1006986824213","article-title":"Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding","volume":"19","author":"Sanchez","year":"1999","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib35","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.1523\/JNEUROSCI.19-12-05034.1999","article-title":"Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression","volume":"19","author":"Sheline","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.11.027_bib37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02244785","article-title":"Increase of extracellular dopamine in the prefrontal cortex: a trait of drugs with antidepressant potential?","volume":"115","author":"Tanda","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.11.027_bib38","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0022-3565(25)11249-4","article-title":"[3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding","volume":"260","author":"Tejani-Butt","year":"1992","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.11.027_bib39","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hipo.20550","article-title":"Hippocampus-dependent learning is associated with adult neurogenesis in MRL\/MpJ mice","volume":"19","author":"Thuret","year":"2009","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2012.11.027_bib40","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2174\/187152707783220910","article-title":"Neurotransmitter regulation of adult neurogenesis: putative therapeutic targets","volume":"6","author":"Vaidya","year":"2007","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.neuropharm.2012.11.027_bib41","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.neubiorev.2010.09.010","article-title":"Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?","volume":"35","author":"Wager-Smith","year":"2011","journal-title":"Neurosci. Biobehav. Rev."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812005746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812005746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T10:53:05Z","timestamp":1745405585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812005746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":41,"alternative-id":["S0028390812005746"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.11.027","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}